Morphic to Present at 2023 RBC Capital Markets Global Healthcare Conference
12 Maio 2023 - 9:30AM
Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company
developing a new generation of oral integrin therapies for the
treatment of serious chronic diseases, today announced that its
management team will participate in a Fireside Chat at the 2023 RBC
Capital Markets Global Healthcare Conference on Wednesday, May 17,
2023.
Fireside Chat InformationDate:
Wednesday May 17, 2023Time: 10:30 AM ETA live webcast of the
presentations will be available on the Investor section of the
Morphic website. An archived replay will be available on the
company’s website following the conference.
About Morphic
TherapeuticMorphic Therapeutic is a biopharmaceutical
company developing a portfolio of oral integrin therapies for the
treatment of serious chronic diseases, including autoimmune,
cardiovascular, and metabolic diseases, fibrosis, and cancer.
Morphic is also advancing its pipeline and discovery activities in
collaboration with Schrödinger using its proprietary MInT
technology platform which leverages the Company’s unique
understanding of integrin structure and biology. For more
information, visit www.morphictx.com.
ContactsMorphic TherapeuticChris
Erdmanchris.erdman@morphictx.com617.686.1718
Morphic (NASDAQ:MORF)
Gráfico Histórico do Ativo
De Mai 2024 até Jun 2024
Morphic (NASDAQ:MORF)
Gráfico Histórico do Ativo
De Jun 2023 até Jun 2024